Related Experiment Video
Updated: Jun 13, 2026
10:21
Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Machine learning algorithms for the prediction of hERG and CYP450 binding in drug development
1Ansaris, Computational Chemistry, Four Valley Square, 512 East Township Line Road, Blue Bell, PA 19422, USA. aklon@ansarisbio.com
Expert Opinion on Drug Metabolism & Toxicology
|May 15, 2010
Summary
Machine learning models can predict drug toxicity, specifically binding to hERG and CYP proteins. This computational approach aids in identifying potential metabolic liabilities early in drug development, reducing costs and failures.
Area of Science:
- Computational chemistry
- Pharmacology
- Drug discovery
Background:
- Drug development costs approximately $1 billion, with significant financial risks from compound withdrawal due to toxicity.
- In silico tools are increasingly important for identifying metabolic liabilities before market entry.
Purpose of the Study:
- To review the use of machine learning (ML) algorithms for predicting binding to the human ether-a-go-go related gene (hERG) ion channel and cytochrome P450 (CYP) isoforms.
- To summarize the advancements in modeling hERG and CYP binding since 2003.
Main Methods:
- Review of machine learning models applied to predict hERG and CYP binding.
- Focus on the two largest classes of ML models used in this domain.
Main Results:
- A variety of ML algorithms demonstrate comparable performance in predicting hERG and CYP binding.
- These models are effective in identifying compounds with potential metabolic liabilities.
Conclusions:
- Machine learning offers a powerful approach to flag compounds with potential toxicities.
- Regular application of these ML methods in discovery projects can mitigate drug development risks and costs.
Related Concept Videos
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:22Protein-Drug Binding: Determination Methods
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...